1 week Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Investor's Business Daily

Amgen stock rebounded Wednesday, shaking off “overdone” fears that its monthly weight-loss shot causes excessive bone mineral density loss.
The post Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? appeared first on Inv…

Amgen (AMGN) · Eli Lilly (LLY)

6 hours Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired DropYahoo Finance X

14 hours Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’Insider Monkey X

18 hours UnitedHealth, Eli Lilly Lead Market Cap Stock Movers on WednesdayInvesting.com X

1 day Is It Time to Sell Eli Lilly and Pfizer Stocks?The Motley Fool X

1 day Is It Time to Sell Eli Lilly and Pfizer Stocks?Yahoo Finance X

1 day The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan StanleyZacks X

2 days Top Research Reports for Eli Lilly, PepsiCo & Morgan StanleyZacks X

2 days LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II StudyZacks X

2 days Here’s Why Eli Lilly and Company (LLY) is on Detractors’ List of Madison Sustainable Equity FundInsider Monkey X

2 days Makers of Weight-Loss Drugs Want Your Employer to Pay for ThemThe Wall Street Journal X

3 days Amgen Sells Off: Keep Calm And Buy The DipSeeking Alpha X

3 days Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowZacks X

3 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItZacks X

3 days Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-203024/7 Wall St. X

3 days 3 Growth Stocks You Can Buy Right Now Without Any HesitationThe Motley Fool X

4 days Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?The Wall Street Journal X

5 days 2 Reasons to Buy Amgen Stock, and 1 Reason to Be CautiousThe Motley Fool X

6 days Three-Stock Lunch: Eli Lilly, Transdigm, & NvidiaYouTube X

6 days Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcareFXStreet X

6 days Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting ProgramYahoo Finance X

6 days Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?The Motley Fool X

7 days Amgen Shrugs Off Bone Density Concerns Related to Obesity CandidateZacks X

7 days Is Eli Lilly Stock A Sell After Its Disastrous Third-Quarter Report?Investor's Business Daily X

1 week Is AstraZeneca a Buy as It Eyes the Weight Loss Market?The Motley Fool X

1 week 2 Top Growth Stocks to Buy on the DipThe Motley Fool X

1 week Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript)Seeking Alpha X

1 week Trade Tracker: Joe Terranova sells Amgen and buys XBIYouTube X

1 week Did Viking Therapeutics Just Say “Checkmate” To Eli Lilly?The Motley Fool X

1 week Amgen dismisses bone density concerns related to its new weight-loss drugInvesting.com X

1 week Amgen sinks as Cantor flags issues with obesity drugYouTube X

1 week Amgen stock falls as analysts mull over weight loss drug’s bone density dataCNBC X

1 week Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity ShotInvestor's Business Daily X

1 week Eli Lilly Falls More Than 10% in a Month: Buy, Sell or Hold the Stock?Zacks X

2 weeks Eli Lilly and Company (LLY): Ken Fisher’s Bet on a Pharma Giant’s Growth PotentialInsider Monkey X

2 weeks 1 Stubborn Cloud and 2 Silver Linings for Eli Lilly StockThe Motley Fool X

2 weeks Eli Lilly and Company (LLY): Among the Best Low Volatility Stocks to Invest In NowInsider Monkey X

2 weeks Micron tops list of 20 biggest winners in the S&P 500 this earnings seasonMarketWatch X

2 weeks Eli Lilly Just Hit a Milestone That Disappointed. Here’s Why You Should Still Buy the Stock.The Motley Fool X

2 weeks What Makes Eli Lilly & Co (LLY) a Prospective Investment?Insider Monkey X

2 weeks Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?The Motley Fool X

2 weeks Missed Out on Eli Lilly? Buy This Amazing Growth Stock InsteadThe Motley Fool X

2 weeks Should Investors Buy Weakness in These High-Growth Stocks?Zacks X

2 weeks Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy Right Now?Insider Monkey X

2 weeks Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded marketFast Company X

2 weeks Big Pharma’s Obesity Bonanza Faces New TestsThe Wall Street Journal X

3 weeks Amgen: A Biotech Giant Offering Value And Growth In A Frothy MarketSeeking Alpha X

3 weeks Could This Near Trillion-Dollar Stock Be a Millionaire Maker?The Motley Fool X

3 weeks Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in FocusZacks X

3 weeks Three Buys and a Bail: Microsoft, Eli Lilly, Peloton, and SnapYouTube X

3 weeks Leerink Partnrs Issues Pessimistic Forecast for LLY EarningsMarketBeat X